Episodic migraine Trials in Miami, United States
Conditions / Episodic migraine / Miami, United States
Clinical trials for Episodic migraine investigate a range of treatment strategies and patient populations.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05127486 | A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine | COMPLETED | PHASE4 |
| NCT03700320 | Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine | COMPLETED | PHASE3 |
| NCT05711394 | A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine | RECRUITING | PHASE3 |
| NCT03939312 | Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine | COMPLETED | PHASE3 |
| NCT03432286 | A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05028569 | Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine | TERMINATED | PHASE3 |
| NCT07018700 | A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine | RECRUITING | — |
| NCT06047457 | A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults | ACTIVE_NOT_RECRUITING | — |
| NCT03927144 | Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients | COMPLETED | PHASE4 |
| NCT03777059 | 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine | COMPLETED | PHASE3 |